Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Investing4d
Jefferies remains bullish on CIGNA stock amid potential benefits from specialty drug exclusivity loss
On Tuesday, Jefferies, a financial services company, raised its price target on shares of Cigna Corporation (NYSE ... Q2 2024 at 19.2. Moreover, Cigna's stock is known for low price volatility ...
Investing4d
Jefferies remains bullish on CIGNA stock amid potential benefits from specialty drug exclusivity loss
On Tuesday, Jefferies, a financial services company, raised its price target on shares of Cigna Corporation (NYSE ... the last twelve months as of Q2 2024 at 19.2. Moreover, Cigna's stock is known for ...
Why Cigna (CI) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Business Insider4d
Jefferies Sticks to Its Buy Rating for Cigna (CI)
In a report released on September 8, RBC Capital also assigned a Buy rating to the stock with a $384.00 price ... Begin your TipRanks Premium journey today. Cigna (CI) Company Description: Founded in ...
ETF Daily News9d
Cigna Investments Inc. New Has $34.44 Million Stock Holdings in Microsoft Co. (NASDAQ:MSFT)
Cigna Investments Inc. New cut its ... PayPay Securities Corp now owns 188 shares of the software giant’s stock worth $71,000 after acquiring an additional 36 shares during the last quarter.
Morningstar1d
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
PBMs owned by CVS, Cigna and UnitedHealth 'artificially inflated' prices for lifesaving medications, regulator alleges The Federal Trade Commission on Friday sued prescription-drug middlemen owned by ...